Recent studies showed that CD44+CD24- cell population (breast cancer stem cell subpopulation) in MCF-7 cells were resistant to tamoxifen treatment, however, tamoxifen resistant cells harbored higher number of CD44+CD24- cell population than MCF-7 cells [32,33]. The gene discussed is CD44; the disease is breast carcinoma.